抗腫瘤藥奧沙利鉑的現(xiàn)有制劑及其展望doc-資料下載頁
2025-07-15 05:02本頁面
【正文】 [ 3] Suzuki R, Takizawa T, KuwataY, et al. Effective anti2tumor activity of oxalip latin encap sulated in transferrin2PEG2liposome[ J ]. Int J Pharm, 2008, 346 (1 /2) : 143 150.[4 ] Amr S,L ila AA, Kizuki S, et al. Oxalip latin encap sula2ted in PEG2coated cationic liposomes induces significanttumor growth supp ression via a dual2targeting app roachin a murine solid tumormodel[ J ]. J Controlled Release,2009, 137 (1) : 8 14.[5 ] L ila AA, Suzuki T, Doi Y, et al. Oxalip latin targeting to angiogenic vessels by PEGylated cationic liposomes sup2p resses the angiogenesis in a dorsal air sac mouse model[ J ]. J Controlled Release, 2009, 134 (1) : 18 25.[ 6 ] 楊美燕. 奧沙利鉑長(zhǎng)循環(huán)熱敏脂質(zhì)體研究[D ]. 北京:軍事醫(yī)學(xué)科學(xué)院, 2007.[ 7 ] Lagarce F, Cruaud O, Deuschel C. Oxalip latin loadedPLAGA microspheres: design of specific release p rofiles[ J ]. Int J Pharm, 2002, 242 (1 2) : 243 246.[ 8 ] 劉 偉. 奧沙利鉑磷脂復(fù)合物的制備及其在靜脈給藥系統(tǒng)中的應(yīng)用研究[D ]. 沈陽: 沈陽藥科大學(xué),2006.[9 ] 楊紅. 順鉑泡囊的研制與抗癌活性研究[D ]. 四川: 四川大學(xué)華西藥學(xué)院,2009.[10 ] 任鵬 孫堅(jiān)彤 沈云玉 黃彩英. 反相高效液相色譜法測(cè)定奧沙利鉑的含量 蘇州: 江蘇省蘇州市第四人民醫(yī)院藥劑科,2005.10 / 10
環(huán)評(píng)公示相關(guān)推薦
鄂ICP備17016276號(hào)-1